...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Synthesis and bioevaluation of new vascular-targeting and anti-angiogenic thieno[2,3-d]pyrimidin-4(3H)-ones
【24h】

Synthesis and bioevaluation of new vascular-targeting and anti-angiogenic thieno[2,3-d]pyrimidin-4(3H)-ones

机译:新血管靶向和抗血管生成噻吩的合成与生物评价[2,3-D]嘧啶-4(3H) - 酮

获取原文
获取原文并翻译 | 示例
           

摘要

A series of forty-six 5,6-annulated 2-arylthieno [2,3-d]pyrimidin-4(3H)-ones were prepared as potentially pleiotropic anticancer drugs with variance in the tubulin-binding trimethoxyphenyl motif at C-2 of a thieno [2,3-d]pyrimidine fragment, enlarged by additional rings of different size and substitution. By assessing their cytotoxicity against various cancer cells, their influence on the polymerization of neat tubulin and the dynamics of microtubule and F-actin cytoskeletons, and their vascular-disrupting and anti-angiogenic activities in vitro and in vivo, structure-activity relations were identified which suggest the 3-iodo-4,5-dimethoxyphenyl substituted thienopyrimidine 2e as a promising anticancer drug candidate for further research. (C) 2020 Elsevier Ltd. All rights reserved.
机译:制备了一系列四十六个5,6-1个链芳基[2,3-D]嘧啶-4(3H)酮,作为潜在的抗体抗癌药物,其具有在C-2中的管蛋白结合三甲氧基苯基基序的差异 噻吩[2,3-d]嘧啶片段,通过额外的不同尺寸和替代的额外响起。 通过对各种癌细胞评估它们的细胞毒性,它们对整齐细胞蛋白的聚合的影响以及微管和F-肌动蛋白细胞骨骼的动力学,以及体外和体内血管破坏和抗血管生成活性,结构 - 活性关系的影响 这表明3-Iodo-4,5-二甲氧基苯基取代的噻吩啶胺2e作为进一步研究的有前途的抗癌药物候选者。 (c)2020 elestvier有限公司保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号